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Abstract
Objective:  To  characterize  the  deaths  of  193  children  with  sickle  cell  disease  screened  by  a
neonatal program  from  1998  to  2012  and  contrast  the  initial  years  with  the  ﬁnal  years.
Methods: Deaths  were  identiﬁed  by  active  surveillance  of  children  absent  to  scheduled  appoint-
ments in  Blood  Bank  Clinical  Centers  (Hemominas).  Clinical  and  epidemiological  data  came  from
death certiﬁcates,  neonatal  screening  database,  medical  records,  and  family  interviews.
Results: Between  1998  and  2012,  3,617,919  children  were  screened  and  2,591  had  sickle  cell
disease (1:1,400).  There  were  193  deaths  (7.4%):  153  with  SS/S0-talassemia,  34  SC  and  6
S+thalassemia;  76.7%  were  younger  than  ﬁve  years;  78%  died  in  the  hospital  and  21%  at
home or  in  transit.  The  main  causes  of  death  were  infection  (45%),  indeterminate  (28%),  and
acute splenic  sequestration  (14%).  In  46%  of  death  certiﬁcates,  the  term  ‘‘sickle  cell’’  was  not
recorded.  Seven-year  death  rate  for  children  born  between  1998  and  2005  was  5.43%  versus
5.12% for  those  born  between  2005  and  2012  (p  =  0.72).  Medical  care  was  provided  to  75%  of
children; 24%  were  unassisted.  Medical  care  was  provided  within  6  hours  of  symptom  onset  in
only half  of  the  interviewed  cases.  In  40.5%  of  cases,  death  occurred  within  the  ﬁrst  24  hours.
Low family  income  was  recorded  in  90%  of  cases,  and  illiteracy  in  5%.
Conclusions:  Although  comprehensive  and  effective,  neonatal  screening  for  sickle  cell  disease
was not  sufﬁcient  to  signiﬁcantly  reduce  mortality  in  a  newborn  screening  program.  Economic
and social  development  and  increase  of  the  knowledge  on  sickle  cell  disease  among  health
professionals  and  family  are  needed  to  overcome  excessive  mortality.
© 2014  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.
 Please cite this article as: Sabarense AP, Lima GO, Silva LM, Viana MB. Characterization of mortality in children with sickle cell disease
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Caracterizac¸ão do  óbito  de  crianc¸as com  doenc¸a falciforme  diagnosticadas  por
Programa  de  Triagem  Neonatal
Resumo
Objetivo:  Caracterizar  os  193  óbitos  de  crianc¸as  com  doenc¸a  falciforme  diagnosticadas  por
programa de  triagem  neonatal  entre  1998-2012  e  comparar  os  primeiros  com  os  últimos  anos.
Métodos: Os  óbitos  foram  identiﬁcados  pela  busca  ativa  das  crianc¸as  ausentes  nas  consultas
agendadas  nos  hemocentros.  Dados  clínicos  e  epidemiológicos  provieram  dos  documentos  de
óbito, banco  de  dados  da  triagem  neonatal,  prontuários  médicos  e  entrevistas  com  familiares.
Resultados:  Entre  1998-2012  foram  triadas  3.617.919  crianc¸as,  2.591  com  doenc¸a  falciforme
(1:1.400). Ocorreram  193  óbitos  (7,4%):  153  com  SS/S0-talassemia,  34  SC  e  6  S+-talassemia;
76,7% em  crianc¸as  com  menos  de  5  anos;  78%  faleceram  em  hospitais  e  21%  em  domicílio  ou
trânsito. Causas  principais  do  óbito:  45%  infecc¸ão,  28%  indeterminada,  14%  sequestro  esplênico
agudo. Em  46%  dos  documentos  de  óbito,  não  houve  registro  do  termo  ‘‘falciforme’’.  A  taxa  de
mortalidade  até  sete  anos  das  crianc¸as  nascidas  entre  1998-2005  foi  5,43%  versus  5,12%,  entre
2005-2012  (p=0,72).  Receberam  assistência  médica  75%  das  crianc¸as;  24%  ﬁcaram  desassistidas.
Pelas entrevistas,  atendimento  médico  teria  ocorrido  nas  primeiras  seis  horas  do  início  dos
sintomas em  metade  dos  casos.  O  óbito  ocorreu  em  40,5%  dos  casos,  nas  primeiras  24  horas.
Baixa renda  familiar  foi  registrada  em  90%  dos  casos  e  analfabetismo  em  5%.
Conclusões:  A  triagem  para  doenc¸a  falciforme,  mesmo  abrangente  e  eﬁcaz,  não  foi  suﬁciente
para reduzir  signiﬁcativamente  a  mortalidade  no  Programa  de  Triagem  Neonatal.  Necessita-se
de desenvolvimento  econômico  e  social  do  estado  e  ampliac¸ão,  pela  educac¸ão  continuada,  do
conhecimento  sobre  a  doenc¸a  falciforme  entre  os  proﬁssionais  de  saúde  e  familiares.
© 2014  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os  direitos
reservados.
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The  NSP-MG  performs  screening  for  SCD  since  March  ofIntroduction
Sickle  cell  disease  (SCD)  comprises  a  group  of  hematologic
disorders  of  genetic  origin,  whose  main  feature  is  the  pre-
dominance  of  hemoglobin  S  (HbS)  in  red  blood  cells.  SCD  has
great  clinical  and  epidemiological  importance,  being  consid-
ered  a  public  health  problem  in  Brazil.1--3HbS  in  homozygous
form  (HbSS),  called  sickle  cell  anemia  (SCA),  is  the  most
common  genotype  and  the  most  severe  clinical  presentation
of  the  disease.  The  concept  of  SCD  also  includes  dou-
ble  heterozygosity  for  HbS  with  other  hemoglobin  variants
(HbSC,  HbSD-Punjab,  and  others)  and  the  interaction  of  HbS
with  beta  thalassemia  (HbS/0 and  HbS/+ thalassemias).4,5
The  main  determinants  of  the  clinical  manifestations  of
the  disease  are  the  vaso-occlusive  phenomena  and  chronic
hemolysis.4
Hemoglobinopathies  are  responsible,  worldwide,  for  3.4%
of  deaths  in  children  under  5  years.6 Patients  with  SCD  have
high  rates  of  morbidity  and  mortality,  mainly  in  developing
countries.7 Even  in  developed  countries,  although  mortality
in  children  has  decreased,  SCD  is  still  a  signiﬁcant  cause  of
mortality  in  adolescents  and  adults.8
A  prevalence  of  25,000-30,000  individuals  with  SCD  is
estimated  in  Brazil,  with  an  incidence  of  3,500  cases  per
year.9 In  the  state  of  Minas  Gerais  (MG),  the  incidence  of
SCD  is  1:1,400  screened  newborns,  based  on  data  from  the
Neonatal  Screening  Program  (NSP-MG).10
A  study  conducted  in  MG10 characterized  the  death  of  78
children  with  SCD  screened  by  the  NSP-MG  in  the  period  of
1998-2005  and  concluded  that  most  deaths  occurred  in  chil-
dren  under  2  years  and  individuals  with  HbSS,  mainly  due  to
1
9
snfection  (septicemia  and  pneumonia).  A  predominance  of
n-hospital  deaths  was  observed;  however,  the  occurrence  of
t  home  or  in-transit  deaths  was  still  signiﬁcant.  An  indeter-
inate  cause  of  death  on  the  death  certiﬁcate  was  frequent,
hich  would  indicate  a  lack  of  knowledge  among  physicians
egarding  SCD  and  acute  events  that  are  determinants  of
eath.
This  study  aimed  to  characterize  the  deaths  of  children
ith  SCD  that  had  been  screened  by  the  NSP-MG  between
998  and  2012.  Whenever  possible,  comparative  analysis  of
eaths  of  children  born  between  March  of  1998  and  February
f  2005  with  those  born  between  March  of  2005  and  Decem-
er  of  2012  was  performed  to  describe  possible  changes
egarding  the  quality  of  care  provided  to  these  children.
ethods
he  population  investigated  in  this  study  consisted  of  117
hildren  diagnosed  with  SCD  at  the  NSP-MG,  followed-up  in
he  Blood  Banks  of  Fundac¸ão  Hemominas,  and  who  died  in
he  period  from  March  1,  2005  to  February  29,  2012.  In  sev-
ral  analyses,  76  deaths  that  occurred  between  March  of
998  and  February  of  2005  were  added  to  the  sample  (of
he  78  deaths  reported,  two  children  were  excluded,  whose
irth  was  prior  to  March  1,1998),10 totaling  193  deaths  and
hus  complementing  the  14  years  of  the  study.998.  All  853  state  municipalities  are  registered.  In  2010,
1.44%  of  the  infants  born  in  the  state  of  Minas  Gerais  were
creened  at  the  Center  for  Diagnostic  Support  Action  and
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thalassemia,  ASS  was  the  cause  of  death  in  17.6%.
Most  children  (75%)  received  medical  care  before  death;
however,  the  number  of  children  that  went  unassisted  (24%)
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esearch  (Núcleo  de  Ac¸ões  e  Pesquisa  em  Apoio  Diagnóstico
NUPAD]),  and  free  medical  treatment  and  follow-up  was
ffered  to  those  born  with  SCD.
The  information  on  death  results  from  an  investigation
onducted  by  the  Control  and  Treatment  Department  of
UPAD  due  to  non-attendance  at  scheduled  consultation  at
he  Blood  Bank.  The  active  searches  performed  encompass
ll  screened  patients  with  SCD  followed-up  at  the  outpatient
linic  of  Fundac¸ão  Hemominas  throughout  the  state.  There-
ore,  it  can  be  stated  that  all  deaths  that  occurred  during
he  study  period  were  recorded.
The  data  for  this  research  came  from  the  NUPAD
atabase,  death  certiﬁcates,  the  Brazilian  Uniﬁed  Health
ystem  database  (DATASUS),  the  Brazilian  Institute  of  Geog-
aphy  and  Statistics  (Instituto  Brasileiro  de  Geograﬁa  e
statística  [IBGE]),  medical  records  of  Fundac¸ão  Hemom-
nas,  and  from  interviews  with  the  children’s  family
embers.
The  information  in  the  NUPAD  database  was  used  to  per-
orm  an  active  search  of  the  117  families  whose  children  had
ied  between  2005  and  2012.  The  interview  was  performed
ith  the  child’s  guardian,  using  a  semistructured  form  used
y  Fernandes  et  al.10 A  total  of  81  families  were  interviewed
y  the  researcher  and  three  families  were  interviewed  by
urses  from  the  referral  Basic  Health  Units.
Five  families  refused  to  be  interviewed,  one  was  unable
o  talk  about  the  subject,  and  27  were  not  located.  The
nterview  covered  ﬁve  aspects:  (1)  death-related  circum-
tances;  (2)  follow-up  of  SCD  and  the  occurrence  of  other
cute  events;  (3)  family’s  socioeconomic  and  cultural  con-
itions,  which  considered  per  capita  income,  education,
arents’  occupation,  and  housing  conditions;  (4)  consider-
tions  about  their  experience  with  the  child;  (5)  applying
he  scale  of  knowledge  on  SCD  to  the  families,  consisting  of
0  questions  with  answer  options:  ‘‘right’’,  ‘‘wrong’’,  or  ‘‘I
on’t  know.’’  The  interview  was  performed  only  after  the
nformed  consent  form  was  signed,  which  encompassed  the
bjectives,  purpose,  and  beneﬁts  of  the  research.
Regarding  the  causes  of  death,  they  were  considered
s  indeterminate  when  the  physicians  showed  ambiguity  in
he  medical  records  of  the  death  certiﬁcate,  regardless  of
here  the  death  occurred  and  whether  the  child  received
ssistance,  thus  making  it  impossible  for  researchers  to
etermine  its  cause.
For  the  statistical  analysis,  comparisons  of  frequencies
etween  nominal  variables  were  made  using  the  chi-squared
est  without  continuity  correction.  Tests  with  a  probability
f  alpha  error  ≤  0.05  were  considered  signiﬁcant.
The  study  was  approved  by  the  Ethics  Committee  of  Uni-
ersidade  Federal  de  Minas  Gerais  (UFMG)  and  Fundac¸ão
emominas.
esults
arch  of  1998  to  February  of  2012  (193  deaths) total  of  3,617,919  children  were  screened  through  the
SP-MG.  Of  these,  2,591  children  had  a  hemoglobin  pro-
le  compatible  with  SCD  and  193  of  them  died  (7.4%),  of
hom  97  (50.3%)  were  males.  Regarding  genotypes,  153  had
F
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S/S0 thalassemia  (79.3%),  34  had  SC-  (17.6%),  and  six  had
+  -thalassemia  (3.1%).
Most  children  who  died  150  (77.7%)  lived  in  urban  areas
f  the  municipalities.  When  the  municipalities  in  the  state
f  Minas  Gerais  that  recorded  deaths  are  considered,  98  of
78  children  diagnosed  with  SCD  (25.9%)  died  in  the  small
unicipalities,  i.e.,  towns  with  up  to  50,000  inhabitants.
his  is  in  contrast  with  the  93  deaths  among  1,228  children
7.6%)  from  medium  or  large-sized  municipalities,  plus  the
arge  cities  (p  <  0.000001).  Two  children  died  out  of  the
tate.
The  median  age  at  blood  collection  for  screening  was  6
ays;  75%  of  the  children  were  screened  at  up  to  8  days
f  life.  The  median  age  at  the  ﬁrst  visit  to  the  Blood  Bank
linical  Center  was  1.4  months.  Twelve  children  (6.2%)  died
rior  to  the  ﬁrst  consultation;  nine  died  before  reaching
0  days,  the  maximum  period  of  waiting  until  the  ﬁrst
onsultation  in  Blood  Banks,  mostly  due  to  prematurity
nd  its  complications,  according  to  the  death  certiﬁcates
ssessed  by  the  researchers.  Three  children  died  at  105,
22,  and  131  days  of  age,  two  of  them  with  severe  congeni-
al  cardiomyopathy.  The  other  child  died  with  acute  splenic
equestration  in  the  city  of  Vitória  (ES),  without  undergoing
he  consultation  at  the  Blood  Bank  in  Valadares  (MG);  two
amilies  were  interviewed  by  the  researchers.
It  was  observed  that  56.5%  of  deaths  occurred  in  chil-
ren  younger  than  2  years  of  age  and  76.7%  occurred  in
hildren  younger  than  5  years.  The  median  age  at  death  was
.7  years.  Fig.  1  shows  the  distribution  by  age  range.
According  to  information  obtained  from  the  death  cer-
iﬁcates  and  interviews  with  family  members,  there  was  a
revalence  of  in-hospital  deaths  (78%),  but  the  occurrence
f  21  home  (11%)  and  19  in-transit  (10%)  deaths  should  be
mphasized.
Infection,  including  septicemia,  pneumonia/acute  chest,
nd  gastroenteritis,  was  the  leading  cause  of  deaths  in  this
roup  (45%),  followed  by  indeterminate  causes  (28%).  Acute
plenic  sequestration  (ASS)  was  the  third  cause  of  death
14%),  as  shown  in  Fig.  2.  Among  the  children  with  SS/S0-igure  1  Distribution,  by  age  group,  of  the  deaths  of  193  chil-
ren with  sickle  cell  disease  who  died  between  March  of  1998
nd February  of  2012.
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Figure  2  Causes  of  death  of  193  children  with  sickle  cell  dis-
ease who  died  between  March  of  1998  and  February  of  2012,
according  to  information  extracted  from  death  certiﬁcates,  the
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ydatabase  of  the  Núcleo  de  Ac¸ões  e  Pesquisa  em  Apoio  Diagnós-
tico (Nupad,  UFMG),  and  interviews.
was  signiﬁcant.  There  was  no  recording  of  the  terms  ‘‘SCD’’
or  ‘‘SCA’’  as  cause  of  death  in  a  signiﬁcant  number  of  death
certiﬁcates  (46%).
March  of  2005  to  February  of  2012  (117  deaths)
The  interviews  (n  =  84)  showed  that  46.4%  of  children  were
treated  within  the  ﬁrst  6  hours  after  symptom  onset  during
the  event  that  caused  the  death;  64.3%,  within  24  hours;
and  26.2%  died  without  medical  attention.  Death  occurred
within  12  hours  of  symptom  onset  in  30%  of  cases  and,  in
40.5%,  within  the  ﬁrst  24  hours.  Fever,  pain,  pallor,  and  vomi-
ting  were  the  most  common  initial  symptoms  related  to
death,  as  reported  by  family  members.  The  hospital  was
the  ﬁrst  health  care  service  sought  by  approximately  60%  of
families,  followed  by  Basic  Health  Units  (12%).
After  the  ﬁrst  consultation,  30  children  were  referred
to  other  care  units,  24  by  ambulance.  Of  these,  three  died
during  transfer  and  one  died  before  transport  arrived.  Only
13.8%  of  the  children  were  transported  while  on  medication.
Regular  use  of  prophylactic  antibiotics  and  folic  acid  was
reported  by  90%  of  the  families.  Approximately  74%  of  the
children  received  special  immunobiologic  agents.  Regarding
the  clinical  evolution  prior  to  death,  58.3%  of  the  children
had  been  admitted  to  the  hospital  at  least  once  and  23.8%,
more  than  three  times.  Painful  crisis  had  occurred  in  almost
60%  of  the  children  before  the  event  which  resulted  in  the
death,  and  46.4%  had  received  transfusions.  ASS  had  already
occurred  in  27.4%  of  the  children.
Regarding  the  socioeconomic  status  of  families,  91.6%
had  a  monthly  per  capita  income  equal  to  or  smaller  than
one  minimum  wage  and  50%  received  federal  beneﬁts.  As
for  education,  5%  of  the  families  were  illiterate.
Only  54.8%  of  the  families  received  regular  visits  of  the
Family  Health  Program  (FHP)  agents  while  the  child  was
alive.  The  cognitive  questionnaire  applied  to  the  families
(n  =  41)  showed  that  85.4%  obtained  over  60%  of  correct
answers.
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Considering  the  total  of  1,733  appointments  scheduled  in
lood  centers  for  the  117  children  who  died,  359  appoint-
ents  (20.7%)  were  not  attended  because  the  families  failed
o  come.  All  appointments  were  rescheduled,  but  the  con-
rol  system  does  not  inform  the  success  of  such  procedure.
omparisons  between  the  study  periods
n  the  ﬁrst  seven  years,  a  total  of  1,399  children  were
creened  and  76  deaths  occurred  until  February  28,  2005,
ith  a  mortality  rate  of  5.43%.  In  the  last  seven  years,  1,192
hildren  were  screened  and  61  died,  with  a  mortality  rate
f  5.12%  (p  =  0.72).  In  the  ﬁrst  period,  55/76  deaths  (72.4%)
ccurred  before  the  age  of  2  years;  in  the  second  period,
7/61  (77.0%,  p  =  0.53).  The  remaining  56  deaths,  totaling
93,  occurred  in  children  born  in  the  ﬁrst  seven  years,  but
ied  in  the  second  period  and  thus,  were  not  included  in  the
tatistical  calculations.
In  the  ﬁrst  seven-year  period,  25.3%  of  the  deaths
ccurred  at  home  or  in  transit;  in  the  second,  the  mortality
ate  decreased  to  18.1%  (p  =  0.28).  The  lack  of  medical  care
t  the  time  of  death  also  decreased  from  28.0%  to  21.6%  (p
 0.39).  The  mentioning  of  the  term  ‘‘sickle  cell’’  in  death
ertiﬁcates  was  signiﬁcantly  more  frequent  (60.5%)  in  the
ast  seven-year  period,  when  compared  to  the  ﬁrst  period
42.1%,  p  =  0.017).
iscussion
he  sample  reﬂects  the  overall  health  reality  of  children
ith  SCD  screened  during  the  14  years  of  the  NSP-MG,  as  all
eaths  of  children  followed  at  Blood  Bank  Clinical  Centers
ere  informed.  This  represents  the  total  number  of  deaths,
hich  conﬁgures  a  population-based  study.
The  present  study,  as  others,11,12 observed  no  signiﬁcant
ifference  between  genders  in  the  incidence  of  deaths  in
he  assessed  age  range.
This  and  several  other  studies11,13--17 have  demonstrated
hat  the  highest  frequency  of  deaths  occurred  in  patients
ith  HbSS  (79.3%),  the  most  common  and  most  clinically
evere  genotype.  The  relatively  high  frequency  of  deaths  in
hildren  with  S+  thalassemia  (6.5%)  does  not  correspond  to
eality,  as  only  from  2010  onwards  all  suspected  cases  of  SCD
n  NSP-MG  were  conﬁrmed  by  molecular  biology  techniques.
he  diagnosis  of  this  subtype  of  SCD  may  be  overestimated  in
he  neonatal  period  due  to  blood  transfusions  not  reported
y  family  members  or  errors  in  the  interpretation  of  small
oncentrations  of  HbA.
Three  quarters  of  the  children  diagnosed  between  2005
nd  2012  underwent  neonatal  screening  for  SCD  in  up  to  8
ays  of  life,  less  time  than  the  18  days  in  the  initial  period
etween  1998  and  2005,10 which  shows  improvement  of  the
SP-MG.
The  distribution  of  children  per  age  range  at  the  time
f  death  shows  increased  occurrence  of  deaths  in  those
ounger  than  5  years,  similar  to  that  observed  by  other
uthors.11,18--22 Nonetheless,  some  authors4,8,12,16,23,24 have
eported  that  infant  mortality  rate  due  to  SCD  is  decreasing
nd  the  median  age  of  death  is  increasing.  In the  present
tudy,  the  high  mortality  in  children  younger  than  5 years  is
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xplained  by  the  higher  incidence  of  potentially  fatal  events
n  this  age  group,  such  as  infections  and  ASS.
Although  in-hospital  deaths  were  the  most  prevalent,  it
s  noteworthy  that  one-ﬁfth  of  them  occurred  at  home  or
n-transit.  This  can  be  explained  by  several  factors,  such
s  family  residence  located  far  from  the  health  service,
ifﬁculty  getting  to  the  service,  low  socioeconomic  and
ducational  levels,  in  addition  to  the  family’s  incapacity
o  identify  risk  situations  for  the  child.  The  statistically
on-signiﬁcant  increase  of  11%  in  the  number  of  in-hospital
eaths  shows  improvement,  albeit  small,  in  the  health  care
f  children  with  SCD  in  the  last  six  years.  A  study  conducted
n  Angola25 concluded  that  patients  with  SCD  who  lived  in  the
ountryside  or  in  rural  communities  were  three  times  more
ikely  to  die  during  hospitalization,  due  to  socioeconomic
actors  and  lack  of  immediate  access  to  medical  care.
In  the  present  study,  as  in  many  others,11,14,15,18,25--27
nfection  appears  as  the  main  cause  of  death,  considering
he  age  groups  studied.  The  high  number  of  indeterminate
auses  suggests  a  difﬁculty  for  physicians  and  health  care
rofessionals  to  recognize  SCD  and  its  severe  acute  events
eterminants  of  death,  as  in  the  study  by  Alves,28 given  that
ost  of  the  records  came  from  in-hospital  deaths.  ASS  was
he  third  most  common  cause,  which  reﬂects  the  difﬁculty
y  health  teams  and  families  to  identify  this  complication.
he  proportion  of  deaths  caused  by  ASS  in  SS  children  was
imilar  to  that  reported  in  a  previous  study,  restricted  to  SS
hildren.29 Other  authors13,15,19 indicated  ASS  as  the  main
ause  of  death  in  children  younger  than  3  years.
A  signiﬁcant  number  (46%)  of  death  certiﬁcates  did  not
ention  the  term  ‘‘sickle  cell’’  as  the  cause  of  death.  How-
ver,  the  number  of  certiﬁcates  that  mention  this  term  has
ncreased  signiﬁcantly  over  the  past  seven  years,  indicating
reater  visibility  and  awareness  of  the  disease  by  physicians.
Most  children  received  medical  care  before  death,  but
5%  of  them  were  unassisted.  An  increase,  albeit  non-
igniﬁcant,  of  13%  in  the  frequency  of  medical  care  provided
o  children  with  SCD  before  death  was  observed,  which  once
gain  indicates  a  probable  increase  of  the  knowledge  about
CD  by  physicians.
Medical  care  occurred  within  the  ﬁrst  6  hours  in  almost
alf  the  cases  and  two-thirds  in  the  period  of  up  to  24  hours.
eath  occurred  within  the  ﬁrst  24  hours  of  symptom  onset
n  approximately  40%  of  cases.  Manci  et  al.15 demonstrated
hat  the  ﬁrst  24  hours  after  the  onset  of  the  pathological
rocess  represent  the  period  of  greatest  risk  of  death  for
atients  with  SCD.  This  emphasizes  how  fast  the  clinical
ondition  worsens,  culminating  in  death.
High  adherence  to  antibiotic  prophylaxis  and  folic  acid,
n  addition  to  the  regular  use  of  special  immunobiologic
gents  indicates  that  these  data  may  be  overestimated,
s  they  were  obtained  a  posteriori  and  in  the  presence  of
n  ‘‘authority  ﬁgure’’,  i.e.,  the  interviewer.  A  study  con-
ucted  at  the  Blood  Bank  Clinical  Center  of  MG  showed
ower  levels  of  adherence  to  antibiotic  prophylaxis.30 The
ncorporation  of  ‘‘special  vaccines’’  to  the  basic  vaccination
chedule  occurred  only  recently,  and  may  have  contributed
o  the  low  adherence  of  families.  This  is  probably  due  to
he  lack  of  awareness  by  health  professionals  regarding  the
pecial  immunization  schedule  and  the  lack  of  priority  when
equesting  special  immunobiologic  agents  by  the  municipal-
ties.
T
h
tSabarense  AP  et  al.
At  the  time  of  the  child’s  death,  only  little  more  than  half
f  the  families  regularly  received  visits  from  the  FHP  team.
onsidering  that  SCD  is  a  chronic  disease  with  the  possibility
f  severe  acute  events,  in  addition  to  the  fact  that  it  affects
ow-income  families,  better  monitoring  by  the  FHP  through
ome  visits  was  expected,  in  order  to  ensure  the  inclusion
f  these  patients  in  the  health  care  system.
Lack  of  priority  and/or  delay  in  treatment,  lack  of  knowl-
dge  by  the  team  and  poor  health  service  infrastructure
ere  difﬁculties  reported  by  the  families  that  may  have  con-
ributed  to  death.  Low  parental  educational  level  and  low
ncome  constitute  additional  barriers.  A study  conducted  in
abon,  Africa,21 also  reported  that  the  vast  majority  (91.3%)
f  children  with  SCD  who  died  were  from  families  of  low
ocioeconomic  status.  Inadequate  transport  conditions  were
lso  reported  by  some  families,  such  as  oxygen  cylinder  with
nsufﬁcient  or  absent  volume  for  the  entire  transfer,  inade-
uate  oxygen  mask  size  for  the  child,  among  others.
The  cognitive  questionnaire  administered  to  41  families
ndicates  that  knowledge  about  SCD  is  still  precarious,  even
fter  the  occurrence  of  such  an  important  event  as  the  death
f  a  child.
The  main  limitation  of  the  study  was  its  retrospective
esign,  as  locating  the  families  becomes  more  difﬁcult  over
he  years,  as  well  as  their  incapacity  to  accurately  report
ome  of  the  data.  The  interviews  added  a  more  accurate
ualitative  character  to  the  study,  rather  than  a  simple
ssessment  of  death  certiﬁcates.  In  the  authors’  opinion,
he  absence  of  33  interviews,  in  117,  did  not  impair  the
esired  goals.
It can  be  concluded  that  low  socioeconomic  and  edu-
ational  levels  of  families,  difﬁculties  in  access  to  health
ervices,  lack  of  transportation,  lack  of  priority  in  health
are,  and  lack  of  knowledge  about  SCD  by  health  profes-
ionals  were  aggravating  factors  for  the  clinical  status  of
he  child.
Screening  for  SCD,  even  when  performed  in  a  comprehen-
ive  and  effective  way,  was  still  not  enough  to  reduce  the
ortality  rate  observed  at  the  NSP-MG.  Social  and  economic
evelopment  in  the  state  are  necessary  to  change  this  sce-
ario.  Care  of  acute  events,  consultations  with  specialists,
dequate  transportation  of  patients,  and  continuing  educa-
ion  for  families  and  health  care  teams  should  be  recognized
s  a  priority  in  the  care  of  patients  with  SCD.
unding
onselho  Nacional  de  Desenvolvimento  Cientíﬁco  e  Tec-
ológico  (CNPq)  and  Núcleo  de  Ac¸ões  e  Pesquisa  em  Apoio
iagnóstico  (Nupad).
onﬂicts of  interest
he  authors  declare  no  conﬂicts  of  interest.
cknowledgmentso  all  the  families  who  agreed  to  be  interviewed  in  their
omes,  despite  the  grief  aroused  by  the  remembrance  of
heir  children’s  death.  To  NUPAD/UFMG,  for  logistical  and
11
1
1
1
2
2
2
2
2
2
2
2
2
2
anemia. J Pediatr (Rio J). 2009;85:163--9.Mortality  of  children  with  sickle  cell  disease  
ﬁnancial  support  at  the  different  stages  of  the  research.  To
CNPq,  which  used  part  of  the  proceeds  from  the  Universal
Demand  Project  No.  471019/2011-9  to  allow  the  perfor-
mance  of  some  visits  for  data  collection.  To  Dr.  Ana  Paula
Fernandes  Pinheiro  Chagas  for  suggesting  the  topic,  as  well
as  her  assistance  and  encouragement  at  all  stages  of  the
research.
References
1. Lobo CL, Ballas SK, Domingos AC, Moura PG, do Nascimento EM,
Cardoso GP, et al. Newborn screening program for hemoglo-
binopathies in Rio de Janeiro. Brazil Pediatr Blood Cancer.
2014;61:34--9.
2. Pereira SA, Brener S, Cardoso CS, Proietti AB. Sickle cell disease:
quality of life in patients with hemoglobin SS and SC disorders.
Rev Bras Hematol Hemoter. 2013;35:325--31.
3. Felix AA, Souza HM, Ribeiro SB. Aspectos epidemiológicos
e sociais da doenc¸a falciforme. Rev Bras Hematol Hemoter.
2010;32:203--8.
4. Quinn CT. Sickle cell disease in childhood: from newborn
screening through transition to adult medical care. Pediatr Clin
North Am. 2013;60:1363--81.
5. Serjeant GR. The natural history of sickle cell disease. Cold
Spring Harb Perspect Med. 2013;3:a011783.
6. Hankins J. Toward high quality medical care for sickle cell dis-
ease: are we there yet? J Pediatr (Rio J). 2010;86:256--8.
7. McGann PT. Sickle cell anemia: an underappreciated and unad-
dressed contributor to global childhood mortality. J Pediatr.
2014;165:18--22.
8. Hamideh D, Alvarez O. Sickle cell disease related mortal-
ity in the United States (1999-2009). Pediatr Blood Cancer.
2013;60:1482--6.
9. Canc¸ado RD, Jesus JA. A doenc¸a falciforme no Brasil. Rev Bras
Hematol Hemoter. 2007;29:204--6.
10. Fernandes AP, Januário JN, Cangussu CB, Macedo DL, Viana MB.
Mortality of children with sickle cell disease: a population study.
J Pediatr (Rio J). 2010;86:279--84.
11. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida
W. Mortality in children and adolescents with sickle cell dis-
ease. Cooperative Study of Sickle Cell Disease. Pediatrics.
1989;84:500--8.
12. Shankar SM, Arbogast PG, Mitchel E, Cooper WO, Wang
WC, Grifﬁn MR. Medical care utilization and mortality in
sickle cell disease: a population-based study. Am J Hematol.
2005;80:262--70.
13. Rogers DW, Clarke JM, Cupidore L, Ramlal AM, Sparke BR,
Serjeant GR. Early deaths in Jamaican children with sickle cell
disease. Br Med J. 1978;1:1515--6.
14. Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover
R, et al. Clinical events in the ﬁrst decade in a cohort of infants
3247
with sickle cell disease. Cooperative Study of Sickle Cell Dis-
ease. Blood. 1995;86:776--83.
5. Manci EA, Culberson DE, Yang YM, Gardner TM, Powell R, Haynes
J Jr, et al. Causes of death in sickle cell disease: an autopsy
study. Br J Haematol. 2003;123:359--65.
6. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with
sickle cell disease. Blood. 2004;103:4023--7.
7. Houston-Yu P, Rana SR, Beyer B, Castro O. Frequent and pro-
longed hospitalizations: a risk factor for early mortality in sickle
cell disease patients. Am J Hematol. 2003;72:201--3.
8. Seeler RA. Deaths in children with sickle cell anemia. A clinical
analysis of 19 fatal instances in Chicago. Clin Pediatr (Phila).
1972;11:634--7.
9. Thomas AN, Pattison C, Serjeant GR. Causes of death in sickle-
cell disease in Jamaica. Br Med J (Clin Res Ed). 1982;285:
633--5.
0. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Stein-
berg MH, et al. Mortality in sickle cell disease. Life expectancy
and risk factors for early death. N Engl J Med. 1994;330:
1639--44.
1. Koko J, Duﬁllot D, M’Ba-Meyo J, Gahouma D, Kani F. Mortality
of children with sickle cell disease in a pediatric department in
Central Africa. Arch Pediatr. 1998;5:965--9.
2. Makani J, Cox SE, Soka D, Komba AN, Oruo J, Mwamtemi H,
et al. Mortality in sickle cell anemia in Africa: a prospective
cohort study in Tanzania. PLoS One. 2011;6:e14699.
3. Loureiro MM. Epidemiologia das internac¸ões hospitalares e
tratamento farmacológico dos eventos agudos em doenc¸as fal-
ciformes [thesis]. Rio de Janeiro: Escola Nacional de Saúde
Pública, Fundac¸ão Oswaldo Cruz; 2006.
4. Yanni E, Grosse SD, Yang Q, Olney RS. Trends in pediatric sickle
cell disease-related mortality in the United States, 1983-2002.
J Pediatr. 2009;154:541--5.
5. Van-Dunem JC, Alves JG, Bernardino L, Figueiroa JN, Braga C,
do Nascimento M, de L, et al. Factors associated with sickle
cell disease mortality among hospitalized Angolan children and
adolescents. West Afr J Med. 2007;26:269--73.
6. Gill FM, Brown A, Gallagher D, Diamond S, Goins E, Grover R,
et al. Newborn experience in the Cooperative Study of Sickle
Cell Disease. Pediatrics. 1989;83:827--9.
7. Miller ST, Sleeper LA, Pegelow CH, Enos LE, Wang WC, Weiner
SJ, et al. Prediction of adverse outcomes in children with sickle
cell disease. N Engl J Med. 2000;342:83--9.
8. Alves AL. Estudo da mortalidade por anemia falciforme. Informe
Epidemiológico do SUS. 1996;5:45--53.
9. Rezende PV, Viana MB, Murao M, Chaves AC, Ribeiro AC. Acute
splenic sequestration in a cohort of children with sickle cell0. Bitarães EL, Oliveira BM, Viana MB. Compliance with antibiotic
prophylaxis in children with sickle cell anemia: a prospective
study. J Pediatr (Rio J). 2008;84:316--22.
